GO:0000790 | nuclear chromatin | 4.58e-05 | 4.48e-01 | 5.263 | 3 | 3 | 109 |
GO:0043044 | ATP-dependent chromatin remodeling | 8.32e-05 | 8.12e-01 | 7.124 | 2 | 2 | 20 |
GO:0005654 | nucleoplasm | 1.03e-04 | 1.00e+00 | 2.993 | 5 | 55 | 876 |
GO:0031492 | nucleosomal DNA binding | 1.31e-04 | 1.00e+00 | 6.802 | 2 | 2 | 25 |
GO:0043234 | protein complex | 3.22e-04 | 1.00e+00 | 4.317 | 3 | 8 | 210 |
GO:0019901 | protein kinase binding | 4.32e-04 | 1.00e+00 | 4.173 | 3 | 11 | 232 |
GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding | 5.10e-04 | 1.00e+00 | 5.831 | 2 | 3 | 49 |
GO:0097252 | oligodendrocyte apoptotic process | 7.17e-04 | 1.00e+00 | 10.446 | 1 | 1 | 1 |
GO:0090343 | positive regulation of cell aging | 7.17e-04 | 1.00e+00 | 10.446 | 1 | 1 | 1 |
GO:0034103 | regulation of tissue remodeling | 7.17e-04 | 1.00e+00 | 10.446 | 1 | 1 | 1 |
GO:0007265 | Ras protein signal transduction | 7.39e-04 | 1.00e+00 | 5.563 | 2 | 3 | 59 |
GO:0090403 | oxidative stress-induced premature senescence | 1.43e-03 | 1.00e+00 | 9.446 | 1 | 1 | 2 |
GO:1901525 | negative regulation of macromitophagy | 1.43e-03 | 1.00e+00 | 9.446 | 1 | 1 | 2 |
GO:0035794 | positive regulation of mitochondrial membrane permeability | 1.43e-03 | 1.00e+00 | 9.446 | 1 | 1 | 2 |
GO:0061024 | membrane organization | 1.67e-03 | 1.00e+00 | 4.970 | 2 | 2 | 89 |
GO:0045893 | positive regulation of transcription, DNA-templated | 1.78e-03 | 1.00e+00 | 3.473 | 3 | 10 | 377 |
GO:0010666 | positive regulation of cardiac muscle cell apoptotic process | 2.15e-03 | 1.00e+00 | 8.861 | 1 | 1 | 3 |
GO:0035033 | histone deacetylase regulator activity | 2.15e-03 | 1.00e+00 | 8.861 | 1 | 1 | 3 |
GO:1902108 | regulation of mitochondrial membrane permeability involved in apoptotic process | 2.15e-03 | 1.00e+00 | 8.861 | 1 | 1 | 3 |
GO:0002360 | T cell lineage commitment | 2.15e-03 | 1.00e+00 | 8.861 | 1 | 1 | 3 |
GO:0051097 | negative regulation of helicase activity | 2.15e-03 | 1.00e+00 | 8.861 | 1 | 1 | 3 |
GO:0030157 | pancreatic juice secretion | 2.86e-03 | 1.00e+00 | 8.446 | 1 | 1 | 4 |
GO:0001940 | male pronucleus | 2.86e-03 | 1.00e+00 | 8.446 | 1 | 1 | 4 |
GO:0002326 | B cell lineage commitment | 2.86e-03 | 1.00e+00 | 8.446 | 1 | 1 | 4 |
GO:0070245 | positive regulation of thymocyte apoptotic process | 2.86e-03 | 1.00e+00 | 8.446 | 1 | 1 | 4 |
GO:0016602 | CCAAT-binding factor complex | 2.86e-03 | 1.00e+00 | 8.446 | 1 | 1 | 4 |
GO:0005829 | cytosol | 3.09e-03 | 1.00e+00 | 1.965 | 5 | 58 | 1787 |
GO:0001221 | transcription cofactor binding | 3.58e-03 | 1.00e+00 | 8.124 | 1 | 1 | 5 |
GO:0030957 | Tat protein binding | 3.58e-03 | 1.00e+00 | 8.124 | 1 | 2 | 5 |
GO:0002309 | T cell proliferation involved in immune response | 3.58e-03 | 1.00e+00 | 8.124 | 1 | 1 | 5 |
GO:0001939 | female pronucleus | 3.58e-03 | 1.00e+00 | 8.124 | 1 | 1 | 5 |
GO:0097371 | MDM2/MDM4 family protein binding | 3.58e-03 | 1.00e+00 | 8.124 | 1 | 1 | 5 |
GO:0000978 | RNA polymerase II core promoter proximal region sequence-specific DNA binding | 4.20e-03 | 1.00e+00 | 4.296 | 2 | 2 | 142 |
GO:0006983 | ER overload response | 4.29e-03 | 1.00e+00 | 7.861 | 1 | 1 | 6 |
GO:0031497 | chromatin assembly | 4.29e-03 | 1.00e+00 | 7.861 | 1 | 1 | 6 |
GO:0007406 | negative regulation of neuroblast proliferation | 4.29e-03 | 1.00e+00 | 7.861 | 1 | 1 | 6 |
GO:0070688 | MLL5-L complex | 4.29e-03 | 1.00e+00 | 7.861 | 1 | 1 | 6 |
GO:2000648 | positive regulation of stem cell proliferation | 5.01e-03 | 1.00e+00 | 7.639 | 1 | 1 | 7 |
GO:0010389 | regulation of G2/M transition of mitotic cell cycle | 5.01e-03 | 1.00e+00 | 7.639 | 1 | 1 | 7 |
GO:0033762 | response to glucagon | 5.01e-03 | 1.00e+00 | 7.639 | 1 | 1 | 7 |
GO:0030126 | COPI vesicle coat | 5.01e-03 | 1.00e+00 | 7.639 | 1 | 1 | 7 |
GO:0090399 | replicative senescence | 5.01e-03 | 1.00e+00 | 7.639 | 1 | 2 | 7 |
GO:0000733 | DNA strand renaturation | 5.72e-03 | 1.00e+00 | 7.446 | 1 | 2 | 8 |
GO:0009303 | rRNA transcription | 5.72e-03 | 1.00e+00 | 7.446 | 1 | 1 | 8 |
GO:0016020 | membrane | 5.97e-03 | 1.00e+00 | 2.209 | 4 | 38 | 1207 |
GO:0031065 | positive regulation of histone deacetylation | 6.44e-03 | 1.00e+00 | 7.276 | 1 | 1 | 9 |
GO:0070266 | necroptotic process | 6.44e-03 | 1.00e+00 | 7.276 | 1 | 1 | 9 |
GO:0031571 | mitotic G1 DNA damage checkpoint | 6.44e-03 | 1.00e+00 | 7.276 | 1 | 2 | 9 |
GO:0046902 | regulation of mitochondrial membrane permeability | 6.44e-03 | 1.00e+00 | 7.276 | 1 | 1 | 9 |
GO:0008266 | poly(U) RNA binding | 6.44e-03 | 1.00e+00 | 7.276 | 1 | 1 | 9 |
GO:0050998 | nitric-oxide synthase binding | 7.15e-03 | 1.00e+00 | 7.124 | 1 | 1 | 10 |
GO:0071850 | mitotic cell cycle arrest | 7.15e-03 | 1.00e+00 | 7.124 | 1 | 1 | 10 |
GO:0032461 | positive regulation of protein oligomerization | 7.15e-03 | 1.00e+00 | 7.124 | 1 | 1 | 10 |
GO:0009651 | response to salt stress | 7.15e-03 | 1.00e+00 | 7.124 | 1 | 1 | 10 |
GO:0042273 | ribosomal large subunit biogenesis | 7.86e-03 | 1.00e+00 | 6.987 | 1 | 3 | 11 |
GO:0070935 | 3'-UTR-mediated mRNA stabilization | 7.86e-03 | 1.00e+00 | 6.987 | 1 | 2 | 11 |
GO:0042149 | cellular response to glucose starvation | 7.86e-03 | 1.00e+00 | 6.987 | 1 | 1 | 11 |
GO:0008340 | determination of adult lifespan | 7.86e-03 | 1.00e+00 | 6.987 | 1 | 1 | 11 |
GO:2000036 | regulation of stem cell maintenance | 7.86e-03 | 1.00e+00 | 6.987 | 1 | 2 | 11 |
GO:0048568 | embryonic organ development | 7.86e-03 | 1.00e+00 | 6.987 | 1 | 1 | 11 |
GO:0045120 | pronucleus | 7.86e-03 | 1.00e+00 | 6.987 | 1 | 1 | 11 |
GO:0035267 | NuA4 histone acetyltransferase complex | 8.57e-03 | 1.00e+00 | 6.861 | 1 | 3 | 12 |
GO:0048205 | COPI coating of Golgi vesicle | 8.57e-03 | 1.00e+00 | 6.861 | 1 | 1 | 12 |
GO:2000378 | negative regulation of reactive oxygen species metabolic process | 8.57e-03 | 1.00e+00 | 6.861 | 1 | 1 | 12 |
GO:0030330 | DNA damage response, signal transduction by p53 class mediator | 9.28e-03 | 1.00e+00 | 6.746 | 1 | 1 | 13 |
GO:0007095 | mitotic G2 DNA damage checkpoint | 9.28e-03 | 1.00e+00 | 6.746 | 1 | 1 | 13 |
GO:0002931 | response to ischemia | 9.28e-03 | 1.00e+00 | 6.746 | 1 | 1 | 13 |
GO:0008156 | negative regulation of DNA replication | 9.28e-03 | 1.00e+00 | 6.746 | 1 | 1 | 13 |
GO:0006978 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator | 1.00e-02 | 1.00e+00 | 6.639 | 1 | 1 | 14 |
GO:0072332 | intrinsic apoptotic signaling pathway by p53 class mediator | 1.00e-02 | 1.00e+00 | 6.639 | 1 | 1 | 14 |
GO:0051721 | protein phosphatase 2A binding | 1.00e-02 | 1.00e+00 | 6.639 | 1 | 1 | 14 |
GO:0030863 | cortical cytoskeleton | 1.07e-02 | 1.00e+00 | 6.539 | 1 | 1 | 15 |
GO:0071158 | positive regulation of cell cycle arrest | 1.07e-02 | 1.00e+00 | 6.539 | 1 | 1 | 15 |
GO:0005657 | replication fork | 1.14e-02 | 1.00e+00 | 6.446 | 1 | 2 | 16 |
GO:0010165 | response to X-ray | 1.21e-02 | 1.00e+00 | 6.359 | 1 | 1 | 17 |
GO:0035035 | histone acetyltransferase binding | 1.21e-02 | 1.00e+00 | 6.359 | 1 | 1 | 17 |
GO:0007369 | gastrulation | 1.21e-02 | 1.00e+00 | 6.359 | 1 | 1 | 17 |
GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER | 1.21e-02 | 1.00e+00 | 6.359 | 1 | 1 | 17 |
GO:0003723 | RNA binding | 1.23e-02 | 1.00e+00 | 3.498 | 2 | 11 | 247 |
GO:0005669 | transcription factor TFIID complex | 1.28e-02 | 1.00e+00 | 6.276 | 1 | 1 | 18 |
GO:0048147 | negative regulation of fibroblast proliferation | 1.28e-02 | 1.00e+00 | 6.276 | 1 | 1 | 18 |
GO:0090200 | positive regulation of release of cytochrome c from mitochondria | 1.28e-02 | 1.00e+00 | 6.276 | 1 | 1 | 18 |
GO:0021549 | cerebellum development | 1.35e-02 | 1.00e+00 | 6.198 | 1 | 1 | 19 |
GO:0000060 | protein import into nucleus, translocation | 1.35e-02 | 1.00e+00 | 6.198 | 1 | 1 | 19 |
GO:0036464 | cytoplasmic ribonucleoprotein granule | 1.35e-02 | 1.00e+00 | 6.198 | 1 | 1 | 19 |
GO:0007569 | cell aging | 1.50e-02 | 1.00e+00 | 6.054 | 1 | 2 | 21 |
GO:2000379 | positive regulation of reactive oxygen species metabolic process | 1.50e-02 | 1.00e+00 | 6.054 | 1 | 1 | 21 |
GO:0019894 | kinesin binding | 1.50e-02 | 1.00e+00 | 6.054 | 1 | 1 | 21 |
GO:0001895 | retina homeostasis | 1.57e-02 | 1.00e+00 | 5.987 | 1 | 1 | 22 |
GO:0051084 | 'de novo' posttranslational protein folding | 1.57e-02 | 1.00e+00 | 5.987 | 1 | 2 | 22 |
GO:0001836 | release of cytochrome c from mitochondria | 1.57e-02 | 1.00e+00 | 5.987 | 1 | 1 | 22 |
GO:0051262 | protein tetramerization | 1.64e-02 | 1.00e+00 | 5.922 | 1 | 2 | 23 |
GO:0016604 | nuclear body | 1.64e-02 | 1.00e+00 | 5.922 | 1 | 1 | 23 |
GO:1900740 | positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway | 1.71e-02 | 1.00e+00 | 5.861 | 1 | 1 | 24 |
GO:0001046 | core promoter sequence-specific DNA binding | 1.71e-02 | 1.00e+00 | 5.861 | 1 | 1 | 24 |
GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator | 1.71e-02 | 1.00e+00 | 5.861 | 1 | 1 | 24 |
GO:0071479 | cellular response to ionizing radiation | 1.71e-02 | 1.00e+00 | 5.861 | 1 | 1 | 24 |
GO:0046677 | response to antibiotic | 1.71e-02 | 1.00e+00 | 5.861 | 1 | 1 | 24 |
GO:0003730 | mRNA 3'-UTR binding | 1.78e-02 | 1.00e+00 | 5.802 | 1 | 2 | 25 |
GO:0005737 | cytoplasm | 1.80e-02 | 1.00e+00 | 1.405 | 5 | 50 | 2633 |
GO:0070062 | extracellular vesicular exosome | 1.81e-02 | 1.00e+00 | 1.766 | 4 | 43 | 1641 |
GO:0034613 | cellular protein localization | 1.85e-02 | 1.00e+00 | 5.746 | 1 | 1 | 26 |
GO:0030971 | receptor tyrosine kinase binding | 1.85e-02 | 1.00e+00 | 5.746 | 1 | 1 | 26 |
GO:0033077 | T cell differentiation in thymus | 1.85e-02 | 1.00e+00 | 5.746 | 1 | 2 | 26 |
GO:0010332 | response to gamma radiation | 1.85e-02 | 1.00e+00 | 5.746 | 1 | 1 | 26 |
GO:0001756 | somitogenesis | 1.92e-02 | 1.00e+00 | 5.691 | 1 | 1 | 27 |
GO:0034644 | cellular response to UV | 1.99e-02 | 1.00e+00 | 5.639 | 1 | 2 | 28 |
GO:0034332 | adherens junction organization | 1.99e-02 | 1.00e+00 | 5.639 | 1 | 1 | 28 |
GO:2001244 | positive regulation of intrinsic apoptotic signaling pathway | 1.99e-02 | 1.00e+00 | 5.639 | 1 | 1 | 28 |
GO:0005507 | copper ion binding | 2.06e-02 | 1.00e+00 | 5.588 | 1 | 1 | 29 |
GO:0070527 | platelet aggregation | 2.06e-02 | 1.00e+00 | 5.588 | 1 | 1 | 29 |
GO:0051402 | neuron apoptotic process | 2.13e-02 | 1.00e+00 | 5.539 | 1 | 2 | 30 |
GO:0001228 | RNA polymerase II transcription regulatory region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription | 2.13e-02 | 1.00e+00 | 5.539 | 1 | 1 | 30 |
GO:0008104 | protein localization | 2.20e-02 | 1.00e+00 | 5.492 | 1 | 2 | 31 |
GO:0001085 | RNA polymerase II transcription factor binding | 2.20e-02 | 1.00e+00 | 5.492 | 1 | 1 | 31 |
GO:0007596 | blood coagulation | 2.25e-02 | 1.00e+00 | 3.041 | 2 | 4 | 339 |
GO:0006284 | base-excision repair | 2.27e-02 | 1.00e+00 | 5.446 | 1 | 8 | 32 |
GO:0021762 | substantia nigra development | 2.41e-02 | 1.00e+00 | 5.359 | 1 | 1 | 34 |
GO:0044267 | cellular protein metabolic process | 2.41e-02 | 1.00e+00 | 2.987 | 2 | 5 | 352 |
GO:0042802 | identical protein binding | 2.44e-02 | 1.00e+00 | 2.978 | 2 | 7 | 354 |
GO:0048146 | positive regulation of fibroblast proliferation | 2.48e-02 | 1.00e+00 | 5.317 | 1 | 1 | 35 |
GO:0005515 | protein binding | 2.53e-02 | 1.00e+00 | 1.021 | 6 | 76 | 4124 |
GO:0022625 | cytosolic large ribosomal subunit | 2.55e-02 | 1.00e+00 | 5.276 | 1 | 2 | 36 |
GO:0035690 | cellular response to drug | 2.69e-02 | 1.00e+00 | 5.198 | 1 | 2 | 38 |
GO:0048511 | rhythmic process | 2.69e-02 | 1.00e+00 | 5.198 | 1 | 1 | 38 |
GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding | 2.83e-02 | 1.00e+00 | 5.124 | 1 | 2 | 40 |
GO:0043525 | positive regulation of neuron apoptotic process | 2.90e-02 | 1.00e+00 | 5.088 | 1 | 1 | 41 |
GO:0000079 | regulation of cyclin-dependent protein serine/threonine kinase activity | 2.90e-02 | 1.00e+00 | 5.088 | 1 | 2 | 41 |
GO:0003684 | damaged DNA binding | 2.90e-02 | 1.00e+00 | 5.088 | 1 | 9 | 41 |
GO:0031100 | organ regeneration | 3.11e-02 | 1.00e+00 | 4.987 | 1 | 2 | 44 |
GO:0045216 | cell-cell junction organization | 3.11e-02 | 1.00e+00 | 4.987 | 1 | 1 | 44 |
GO:0051087 | chaperone binding | 3.18e-02 | 1.00e+00 | 4.954 | 1 | 3 | 45 |
GO:0002039 | p53 binding | 3.18e-02 | 1.00e+00 | 4.954 | 1 | 2 | 45 |
GO:0019903 | protein phosphatase binding | 3.32e-02 | 1.00e+00 | 4.891 | 1 | 3 | 47 |
GO:0097193 | intrinsic apoptotic signaling pathway | 3.46e-02 | 1.00e+00 | 4.831 | 1 | 1 | 49 |
GO:0016032 | viral process | 3.48e-02 | 1.00e+00 | 2.705 | 2 | 32 | 428 |
GO:0002020 | protease binding | 3.53e-02 | 1.00e+00 | 4.802 | 1 | 1 | 50 |
GO:0006302 | double-strand break repair | 3.67e-02 | 1.00e+00 | 4.746 | 1 | 8 | 52 |
GO:0006289 | nucleotide-excision repair | 3.74e-02 | 1.00e+00 | 4.718 | 1 | 9 | 53 |
GO:0034329 | cell junction assembly | 3.74e-02 | 1.00e+00 | 4.718 | 1 | 1 | 53 |
GO:0030512 | negative regulation of transforming growth factor beta receptor signaling pathway | 3.74e-02 | 1.00e+00 | 4.718 | 1 | 1 | 53 |
GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest | 3.74e-02 | 1.00e+00 | 4.718 | 1 | 17 | 53 |
GO:0035264 | multicellular organism growth | 3.81e-02 | 1.00e+00 | 4.691 | 1 | 1 | 54 |
GO:0005681 | spliceosomal complex | 3.88e-02 | 1.00e+00 | 4.665 | 1 | 2 | 55 |
GO:0050731 | positive regulation of peptidyl-tyrosine phosphorylation | 3.95e-02 | 1.00e+00 | 4.639 | 1 | 1 | 56 |
GO:0032355 | response to estradiol | 4.02e-02 | 1.00e+00 | 4.613 | 1 | 1 | 57 |
GO:0000785 | chromatin | 4.15e-02 | 1.00e+00 | 4.563 | 1 | 5 | 59 |
GO:0005179 | hormone activity | 4.22e-02 | 1.00e+00 | 4.539 | 1 | 1 | 60 |
GO:0071013 | catalytic step 2 spliceosome | 4.29e-02 | 1.00e+00 | 4.515 | 1 | 5 | 61 |
GO:0019083 | viral transcription | 4.29e-02 | 1.00e+00 | 4.515 | 1 | 2 | 61 |
GO:0006415 | translational termination | 4.43e-02 | 1.00e+00 | 4.469 | 1 | 2 | 63 |
GO:0047485 | protein N-terminus binding | 4.57e-02 | 1.00e+00 | 4.424 | 1 | 2 | 65 |
GO:0006364 | rRNA processing | 4.71e-02 | 1.00e+00 | 4.380 | 1 | 4 | 67 |
GO:0005200 | structural constituent of cytoskeleton | 4.78e-02 | 1.00e+00 | 4.359 | 1 | 2 | 68 |
GO:0006414 | translational elongation | 4.84e-02 | 1.00e+00 | 4.338 | 1 | 2 | 69 |
GO:0006928 | cellular component movement | 4.91e-02 | 1.00e+00 | 4.317 | 1 | 1 | 70 |
GO:0038096 | Fc-gamma receptor signaling pathway involved in phagocytosis | 4.91e-02 | 1.00e+00 | 4.317 | 1 | 1 | 70 |
GO:0030308 | negative regulation of cell growth | 4.91e-02 | 1.00e+00 | 4.317 | 1 | 2 | 70 |
GO:0006325 | chromatin organization | 4.91e-02 | 1.00e+00 | 4.317 | 1 | 3 | 70 |
GO:0014069 | postsynaptic density | 5.12e-02 | 1.00e+00 | 4.256 | 1 | 1 | 73 |
GO:0016363 | nuclear matrix | 5.12e-02 | 1.00e+00 | 4.256 | 1 | 7 | 73 |
GO:0001649 | osteoblast differentiation | 5.19e-02 | 1.00e+00 | 4.237 | 1 | 2 | 74 |
GO:0010467 | gene expression | 5.24e-02 | 1.00e+00 | 2.383 | 2 | 31 | 535 |
GO:0071456 | cellular response to hypoxia | 5.32e-02 | 1.00e+00 | 4.198 | 1 | 2 | 76 |
GO:0006614 | SRP-dependent cotranslational protein targeting to membrane | 5.39e-02 | 1.00e+00 | 4.179 | 1 | 2 | 77 |
GO:0019058 | viral life cycle | 5.46e-02 | 1.00e+00 | 4.161 | 1 | 3 | 78 |
GO:0016605 | PML body | 5.53e-02 | 1.00e+00 | 4.142 | 1 | 4 | 79 |
GO:0072562 | blood microparticle | 5.67e-02 | 1.00e+00 | 4.106 | 1 | 2 | 81 |
GO:0030529 | ribonucleoprotein complex | 5.73e-02 | 1.00e+00 | 4.088 | 1 | 4 | 82 |
GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay | 5.87e-02 | 1.00e+00 | 4.054 | 1 | 3 | 84 |
GO:0003700 | sequence-specific DNA binding transcription factor activity | 6.10e-02 | 1.00e+00 | 2.261 | 2 | 6 | 582 |
GO:0044255 | cellular lipid metabolic process | 6.21e-02 | 1.00e+00 | 3.970 | 1 | 2 | 89 |
GO:0006886 | intracellular protein transport | 6.21e-02 | 1.00e+00 | 3.970 | 1 | 2 | 89 |
GO:0006461 | protein complex assembly | 6.35e-02 | 1.00e+00 | 3.938 | 1 | 3 | 91 |
GO:0007050 | cell cycle arrest | 6.41e-02 | 1.00e+00 | 3.922 | 1 | 3 | 92 |
GO:0007219 | Notch signaling pathway | 6.62e-02 | 1.00e+00 | 3.876 | 1 | 4 | 95 |
GO:0000086 | G2/M transition of mitotic cell cycle | 6.75e-02 | 1.00e+00 | 3.846 | 1 | 5 | 97 |
GO:0006457 | protein folding | 6.75e-02 | 1.00e+00 | 3.846 | 1 | 4 | 97 |
GO:0006413 | translational initiation | 6.89e-02 | 1.00e+00 | 3.817 | 1 | 4 | 99 |
GO:0005198 | structural molecule activity | 7.02e-02 | 1.00e+00 | 3.788 | 1 | 1 | 101 |
GO:0045944 | positive regulation of transcription from RNA polymerase II promoter | 7.31e-02 | 1.00e+00 | 2.115 | 2 | 8 | 644 |
GO:0007179 | transforming growth factor beta receptor signaling pathway | 7.42e-02 | 1.00e+00 | 3.705 | 1 | 1 | 107 |
GO:0005615 | extracellular space | 7.45e-02 | 1.00e+00 | 2.100 | 2 | 8 | 651 |
GO:0003735 | structural constituent of ribosome | 7.56e-02 | 1.00e+00 | 3.678 | 1 | 2 | 109 |
GO:0042981 | regulation of apoptotic process | 7.76e-02 | 1.00e+00 | 3.639 | 1 | 18 | 112 |
GO:0006974 | cellular response to DNA damage stimulus | 8.36e-02 | 1.00e+00 | 3.527 | 1 | 3 | 121 |
GO:0006355 | regulation of transcription, DNA-templated | 8.79e-02 | 1.00e+00 | 1.964 | 2 | 7 | 715 |
GO:0030424 | axon | 8.83e-02 | 1.00e+00 | 3.446 | 1 | 2 | 128 |
GO:0000398 | mRNA splicing, via spliceosome | 8.83e-02 | 1.00e+00 | 3.446 | 1 | 8 | 128 |
GO:0001077 | RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription | 9.09e-02 | 1.00e+00 | 3.402 | 1 | 1 | 132 |
GO:0031625 | ubiquitin protein ligase binding | 9.49e-02 | 1.00e+00 | 3.338 | 1 | 5 | 138 |
GO:0005759 | mitochondrial matrix | 9.55e-02 | 1.00e+00 | 3.327 | 1 | 5 | 139 |
GO:0044212 | transcription regulatory region DNA binding | 9.81e-02 | 1.00e+00 | 3.286 | 1 | 2 | 143 |
GO:0001701 | in utero embryonic development | 1.05e-01 | 1.00e+00 | 3.179 | 1 | 3 | 154 |
GO:0044822 | poly(A) RNA binding | 1.07e-01 | 1.00e+00 | 1.804 | 2 | 25 | 799 |
GO:0008380 | RNA splicing | 1.12e-01 | 1.00e+00 | 3.080 | 1 | 7 | 165 |
GO:0007067 | mitotic nuclear division | 1.12e-01 | 1.00e+00 | 3.080 | 1 | 8 | 165 |
GO:0016071 | mRNA metabolic process | 1.16e-01 | 1.00e+00 | 3.037 | 1 | 21 | 170 |
GO:0000166 | nucleotide binding | 1.20e-01 | 1.00e+00 | 2.987 | 1 | 6 | 176 |
GO:0006412 | translation | 1.21e-01 | 1.00e+00 | 2.970 | 1 | 3 | 178 |
GO:0016070 | RNA metabolic process | 1.27e-01 | 1.00e+00 | 2.891 | 1 | 21 | 188 |
GO:0005524 | ATP binding | 1.29e-01 | 1.00e+00 | 1.645 | 2 | 23 | 892 |
GO:0005856 | cytoskeleton | 1.29e-01 | 1.00e+00 | 2.876 | 1 | 2 | 190 |
GO:0043065 | positive regulation of apoptotic process | 1.36e-01 | 1.00e+00 | 2.788 | 1 | 3 | 202 |
GO:0030154 | cell differentiation | 1.37e-01 | 1.00e+00 | 2.774 | 1 | 3 | 204 |
GO:0008134 | transcription factor binding | 1.41e-01 | 1.00e+00 | 2.739 | 1 | 4 | 209 |
GO:0019899 | enzyme binding | 1.41e-01 | 1.00e+00 | 2.732 | 1 | 4 | 210 |
GO:0003677 | DNA binding | 1.42e-01 | 1.00e+00 | 1.559 | 2 | 18 | 947 |
GO:0007275 | multicellular organismal development | 1.44e-01 | 1.00e+00 | 2.705 | 1 | 4 | 214 |
GO:0007411 | axon guidance | 1.58e-01 | 1.00e+00 | 2.557 | 1 | 1 | 237 |
GO:0008283 | cell proliferation | 1.59e-01 | 1.00e+00 | 2.545 | 1 | 6 | 239 |
GO:0003682 | chromatin binding | 1.67e-01 | 1.00e+00 | 2.469 | 1 | 6 | 252 |
GO:0005634 | nucleus | 1.72e-01 | 1.00e+00 | 0.782 | 4 | 67 | 3246 |
GO:0046982 | protein heterodimerization activity | 1.75e-01 | 1.00e+00 | 2.396 | 1 | 5 | 265 |
GO:0008285 | negative regulation of cell proliferation | 1.82e-01 | 1.00e+00 | 2.332 | 1 | 4 | 277 |
GO:0005925 | focal adhesion | 1.86e-01 | 1.00e+00 | 2.306 | 1 | 4 | 282 |
GO:0000278 | mitotic cell cycle | 2.05e-01 | 1.00e+00 | 2.151 | 1 | 35 | 314 |
GO:0045892 | negative regulation of transcription, DNA-templated | 2.06e-01 | 1.00e+00 | 2.138 | 1 | 7 | 317 |
GO:0043066 | negative regulation of apoptotic process | 2.09e-01 | 1.00e+00 | 2.115 | 1 | 20 | 322 |
GO:0005730 | nucleolus | 2.14e-01 | 1.00e+00 | 1.197 | 2 | 41 | 1217 |
GO:0006366 | transcription from RNA polymerase II promoter | 2.20e-01 | 1.00e+00 | 2.032 | 1 | 6 | 341 |
GO:0005783 | endoplasmic reticulum | 2.43e-01 | 1.00e+00 | 1.872 | 1 | 3 | 381 |
GO:0006915 | apoptotic process | 2.60e-01 | 1.00e+00 | 1.763 | 1 | 21 | 411 |
GO:0045087 | innate immune response | 2.82e-01 | 1.00e+00 | 1.626 | 1 | 7 | 452 |
GO:0000122 | negative regulation of transcription from RNA polymerase II promoter | 2.85e-01 | 1.00e+00 | 1.613 | 1 | 4 | 456 |
GO:0005739 | mitochondrion | 3.87e-01 | 1.00e+00 | 1.082 | 1 | 11 | 659 |
GO:0008270 | zinc ion binding | 4.18e-01 | 1.00e+00 | 0.940 | 1 | 7 | 727 |
GO:0044281 | small molecule metabolic process | 4.69e-01 | 1.00e+00 | 0.725 | 1 | 32 | 844 |